• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种简单快速的 LC-MS/MS 法同时测定人血浆中替诺福韦艾拉酚胺和替诺福韦。

A simple and fast LC-MS/MS method for the simultaneous determination of tenofovir alafenamide and tenofovir in human plasma.

机构信息

The Affiliated Suzhou Science and Technology Town Hospital of Nanjing Medical University, Suzhou, China.

Suzhou Haike Medical Technology Co. Ltd., Suzhou, China.

出版信息

Biomed Chromatogr. 2022 Mar;36(3):e5273. doi: 10.1002/bmc.5273. Epub 2021 Dec 8.

DOI:10.1002/bmc.5273
PMID:34725843
Abstract

A simple and fast liquid chromatography-tandem mass spectrometry method was established and validated for the simultaneous determination of tenofovir alafenamide (TAF) and tenofovir (TNF) in human plasma. A simple protein precipitation procedure was employed to extract analytes from plasma. Chromatographic separation was performed on an Eclipse Plus C column utilizing a fast gradient elution starting with 2% of 2 mM ammonium acetate-formic acid (100/0.1, v/v) followed by increasing the percentage of acetonitrile. Detection was performed on a tandem mass spectrometer equipped with an electrospray ionization source operated in the positive ionization mode, using the transitions m/z 477.2 → m/z 346.1 for TAF and m/z 288.1 → m/z 176.1 for TNF. TAF-d and TNF-d were used as the internal standard of TAF and TNF, respectively. The method was validated in the concentration ranges 1.25-500 ng/mlfor TAF and 0.300-15.0 ng/ml for TNF with acceptable accuracy and precision.

摘要

建立并验证了一种用于同时测定人血浆中替诺福韦艾拉酚胺(TAF)和替诺福韦(TNF)的简单、快速的液相色谱-串联质谱法。采用简单的蛋白沉淀法从血浆中提取分析物。采用 Eclipse Plus C 柱进行色谱分离,以 2%的 2 mM 乙酸铵-甲酸(100/0.1,v/v)为起始,快速梯度洗脱,然后逐渐增加乙腈的比例。采用电喷雾电离源的串联质谱仪进行检测,正离子模式下操作,TAF 的监测离子对为 m/z 477.2→m/z 346.1,TNF 的监测离子对为 m/z 288.1→m/z 176.1。TAF-d 和 TNF-d 分别作为 TAF 和 TNF 的内标。该方法在 TAF 的浓度范围为 1.25-500ng/ml 和 TNF 的浓度范围为 0.300-15.0ng/ml 时具有可接受的准确度和精密度。

相似文献

1
A simple and fast LC-MS/MS method for the simultaneous determination of tenofovir alafenamide and tenofovir in human plasma.一种简单快速的 LC-MS/MS 法同时测定人血浆中替诺福韦艾拉酚胺和替诺福韦。
Biomed Chromatogr. 2022 Mar;36(3):e5273. doi: 10.1002/bmc.5273. Epub 2021 Dec 8.
2
Simultaneous determination of tenofovir alafenamide and tenofovir in human plasma by LC-MS/MS and its application to pharmacokinetics study in clinic.采用 LC-MS/MS 法同时测定人血浆中替诺福韦艾拉酚胺和替诺福韦的浓度及其在临床药代动力学研究中的应用。
J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Jun 1;1117:148-157. doi: 10.1016/j.jchromb.2019.04.011. Epub 2019 Apr 5.
3
Development and validation of an LC-MS/MS assay for tenofovir and tenofovir alafenamide in human plasma and cerebrospinal fluid.建立并验证人血浆和脑脊液中替诺福韦和替诺福韦艾拉酚胺的 LC-MS/MS 检测方法。
J Pharm Biomed Anal. 2018 Jul 15;156:163-169. doi: 10.1016/j.jpba.2018.04.035. Epub 2018 Apr 23.
4
An LC-MS/MS method for determination of tenofovir (TFV) in human plasma following tenofovir alafenamide (TAF) administration: Development, validation, cross-validation, and use of formic acid as plasma TFV stabilizer.一种 LC-MS/MS 法测定人血浆中替诺福韦(TFV)在替诺福韦艾拉酚胺(TAF)给药后的浓度:开发、验证、交叉验证和使用甲酸作为血浆 TFV 稳定剂。
Anal Biochem. 2020 Mar 15;593:113611. doi: 10.1016/j.ab.2020.113611. Epub 2020 Feb 5.
5
Validation and implementation of liquid chromatographic-mass spectrometric (LC-MS) methods for the quantification of tenofovir prodrugs.验证和实施液相色谱-质谱(LC-MS)方法,用于定量测定替诺福韦前药。
J Pharm Biomed Anal. 2018 Apr 15;152:248-256. doi: 10.1016/j.jpba.2018.02.011. Epub 2018 Feb 8.
6
Determination of abacavir, tenofovir, darunavir, and raltegravir in human plasma and saliva using liquid chromatography coupled with tandem mass spectrometry.采用液相色谱-串联质谱法测定人血浆和唾液中的阿巴卡韦、替诺福韦、达芦那韦和拉替拉韦。
J Pharm Biomed Anal. 2015 Oct 10;114:390-7. doi: 10.1016/j.jpba.2015.06.005. Epub 2015 Jun 10.
7
Simultaneous determination of phentermine and topiramate in human plasma by liquid chromatography-tandem mass spectrometry with positive/negative ion-switching electrospray ionization and its application in pharmacokinetic study.液相色谱-串联质谱法结合正/负离子切换电喷雾电离同时测定人血浆中苯丁胺和托吡酯及其在药代动力学研究中的应用
J Pharm Biomed Anal. 2015 Mar 25;107:444-9. doi: 10.1016/j.jpba.2015.01.035. Epub 2015 Jan 24.
8
High-sensitivity liquid chromatography-tandem mass spectrometry method for the simultaneous determination of sodium picosulfate and its three major metabolites in human plasma.高灵敏度液相色谱-串联质谱法同时测定人血浆中匹可硫酸钠及其三种主要代谢物。
J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Feb 1;915-916:1-7. doi: 10.1016/j.jchromb.2012.12.007. Epub 2012 Dec 20.
9
High-throughput salting-out-assisted liquid-liquid extraction for the simultaneous determination of atorvastatin, ortho-hydroxyatorvastatin, and para-hydroxyatorvastatin in human plasma using ultrafast liquid chromatography with tandem mass spectrometry.高通量盐析辅助液液萃取-超快速液相色谱-串联质谱法同时测定人血浆中阿托伐他汀、邻羟基阿托伐他汀和对羟基阿托伐他汀
J Sep Sci. 2015 Mar;38(6):1026-34. doi: 10.1002/jssc.201401227. Epub 2015 Feb 14.
10
Simultaneous determination of asperosaponin VI and its active metabolite hederagenin in rat plasma by liquid chromatography-tandem mass spectrometry with positive/negative ion-switching electrospray ionization and its application in pharmacokinetic study.采用正负离子切换电喷雾电离的液相色谱-串联质谱法同时测定大鼠血浆中的asperosaponin VI 及其活性代谢物hederagenin 及其在药代动力学研究中的应用。
J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Nov 15;879(30):3407-14. doi: 10.1016/j.jchromb.2011.09.014. Epub 2011 Sep 13.

引用本文的文献

1
Novel Micro-LC-MS/MS Method for the Quantification of Tenofovir and Its Active Metabolite Tenofovir-Diphosphate in Biological Matrices for Therapeutic Drug Monitoring.用于治疗药物监测的生物基质中替诺福韦及其活性代谢物替诺福韦二磷酸定量的新型微液相色谱-串联质谱法
Pharmaceuticals (Basel). 2025 Jun 16;18(6):899. doi: 10.3390/ph18060899.
2
Pharmacokinetic Feasibility of Stability-Enhanced Solid-State (SESS) Tenofovir Disoproxil Free Base Crystal.稳定性增强的固态(SESS)替诺福韦酯游离碱晶体的药代动力学可行性
Pharmaceutics. 2023 May 1;15(5):1392. doi: 10.3390/pharmaceutics15051392.